SCOK [Hongli Clean Energy Technologies] DEF 14A:
[]
[TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3 EX-101 INSTANCE DOCUMENT EX-101HEMA DOCUMENT EX-101LCULATION LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EXPLANATORY NOTE No other changes have been made to the Annual Report. This Amendment does not reflect events that have occurred after the April27, 2011 filingte of]
[CUSIP No. G210821050 Page 2 of 8 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 o 6 CITIZENSHIP OR PLACE OF ORGANIZATION Hong Kong 7]
[CUSIP No. G210821050 Page 2 of 8 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 o 6 CITIZENSHIP OR PLACE OF ORGANIZATION Hong Kong 7]
[Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share Repurchase Plan Rule 10b5-1 permitsrporate officers, directors and others toopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These planslow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]